CR, G., D, C., RM, W., CL, C., AM, N., TJ, F., . . . SM, S. (2011). Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT. Investigational new drugs, 29(6), 1381. https://doi.org/10.1007/s10637-010-9479-2
Chicago Style (17th ed.) CitationCR, Garrett, et al. "Phase I Pharmacokinetic and Pharmacodynamic Study of Triciribine Phosphate Monohydrate, a Small-molecule Inhibitor of AKT Phosphorylation, in Adult Subjects with Solid Tumors Containing Activated AKT." Investigational New Drugs 29, no. 6 (2011): 1381. https://doi.org/10.1007/s10637-010-9479-2.
MLA (9th ed.) CitationCR, Garrett, et al. "Phase I Pharmacokinetic and Pharmacodynamic Study of Triciribine Phosphate Monohydrate, a Small-molecule Inhibitor of AKT Phosphorylation, in Adult Subjects with Solid Tumors Containing Activated AKT." Investigational New Drugs, vol. 29, no. 6, 2011, p. 1381, https://doi.org/10.1007/s10637-010-9479-2.